Read + Share
Zhang X, Liu JR, Mu ZZ, Cheng XQ, et al. Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in
Intermediate-risk Papillary Thyroid Cancer. J Clin Endocrinol Metab 2022 Dec 26:dgac745. doi: 10.1210.
PMID: 36567646
|
 |
|
Zhang X, Liu JR, Mu ZZ, Cheng XQ, et al. Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in
Intermediate-risk Papillary Thyroid Cancer. J Clin Endocrinol Metab 2022 Dec 26:dgac745. doi: 10.1210.
PMID: 36567646
|
|
|
|